176 related articles for article (PubMed ID: 34392854)
1. Modified Mediterranean diet
Bohlouli J; Namjoo I; Borzoo-Isfahani M; Poorbaferani F; Moravejolahkami AR; Clark CCT; Hojjati Kermani MA
Br J Nutr; 2022 Oct; 128(7):1274-1284. PubMed ID: 34392854
[TBL] [Abstract][Full Text] [Related]
2. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
[TBL] [Abstract][Full Text] [Related]
3. Association of self-reported adherence to the Mediterranean diet with anthropometric indices, comorbidities, and degree of disability in patients with multiple sclerosis.
Farzinmehr S; Hosseini S; Kamali H; Moghadasi AN; Poursadeghfard M; Sharifi MH
Mult Scler Relat Disord; 2022 Oct; 66():104060. PubMed ID: 35908448
[TBL] [Abstract][Full Text] [Related]
4. Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients.
Cavallari M; Palotai M; Glanz BI; Egorova S; Prieto JC; Healy BC; Chitnis T; Guttmann CR
Mult Scler; 2016 Dec; 22(14):1841-1849. PubMed ID: 26920374
[TBL] [Abstract][Full Text] [Related]
5. The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial.
Mousavi-Shirazi-Fard Z; Mazloom Z; Izadi S; Fararouei M
Int J Neurosci; 2021 Jul; 131(7):657-665. PubMed ID: 32249637
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Ghajarzadeh M; Jalilian R; Eskandari G; Ali Sahraian M; Reza Azimi A
Disabil Rehabil; 2013 Aug; 35(18):1509-12. PubMed ID: 23237227
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F
Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582
[TBL] [Abstract][Full Text] [Related]
9. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study.
Katz Sand I; Benn EKT; Fabian M; Fitzgerald KC; Digga E; Deshpande R; Miller A; Gallo S; Arab L
Mult Scler Relat Disord; 2019 Nov; 36():101403. PubMed ID: 31610401
[TBL] [Abstract][Full Text] [Related]
10. Association of dietary patterns with systemic inflammation, quality of life, disease severity, relapse rate, severity of fatigue and anthropometric measurements in MS patients.
Moravejolahkami AR; Paknahad Z; Chitsaz A
Nutr Neurosci; 2020 Dec; 23(12):920-930. PubMed ID: 30896320
[No Abstract] [Full Text] [Related]
11. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
12. Erratum.
Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness of a cognitive behavioural therapy (CBT) in the management of fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a multicentre, randomised, open-label, controlled trial versus standard care.
Gay MC; Cassedanne F; Barbot F; Vaugier I; Thomas S; Manchon E; Bensmail D; Blanchere M; Heinzlef O
J Neurol Neurosurg Psychiatry; 2024 Jan; 95(2):158-166. PubMed ID: 37648439
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Motor Disability and the Level of Fatigue on Adherence to Therapeutic Recommendations in Patients with Multiple Sclerosis Treated with Immunomodulation.
Ślusarz R; Olkiewicz J; Bonek R; Filipska K; Biercewicz M; Wiśniewski A
Int J Med Sci; 2021; 18(15):3609-3614. PubMed ID: 34522188
[No Abstract] [Full Text] [Related]
15. Combined associations of body mass index and adherence to a Mediterranean-like diet with all-cause and cardiovascular mortality: A cohort study.
Michaëlsson K; Baron JA; Byberg L; Höijer J; Larsson SC; Svennblad B; Melhus H; Wolk A; Warensjö Lemming E
PLoS Med; 2020 Sep; 17(9):e1003331. PubMed ID: 32941436
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of diet on fatigue, quality of life and disability status in multiple sclerosis patients: rapid review and meta-analysis of randomized controlled trials.
Guerrero Aznar MD; Villanueva Guerrero MD; Cordero Ramos J; Eichau Madueño S; Morales Bravo M; López Ruiz R; Beltrán García M
BMC Neurol; 2022 Oct; 22(1):388. PubMed ID: 36266639
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-Inflammatory-antioxidant-rich diet and co-supplemented synbiotics intervention in patients with progressive forms of multiple sclerosis: a single-center, single-blind randomized clinical trial.
Moravejolahkami AR; Chitsaz A; Hassanzadeh A; Paknahad Z
Nutr Neurosci; 2023 Nov; 26(11):1078-1089. PubMed ID: 36173031
[TBL] [Abstract][Full Text] [Related]
18. A comparison between two healthy diet scores, the modified Mediterranean diet score and the Healthy Nordic Food Index, in relation to all-cause and cause-specific mortality.
Warensjö Lemming E; Byberg L; Wolk A; Michaëlsson K
Br J Nutr; 2018 Apr; 119(7):836-846. PubMed ID: 29569544
[TBL] [Abstract][Full Text] [Related]
19. Measuring productivity loss in early relapsing-remitting multiple sclerosis.
Sainz de la Maza S; Maurino J; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Campo-Amigo MD; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; de Alda LR; Gómez-Ballesteros R; Castillo-Triviño T
Mult Scler Relat Disord; 2022 Feb; 58():103398. PubMed ID: 35216781
[TBL] [Abstract][Full Text] [Related]
20. Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies.
Kita M; Fox RJ; Gold R; Giovannoni G; Phillips JT; Sarda SP; Kong J; Viglietta V; Sheikh SI; Okwuokenye M; Kappos L
Clin Ther; 2014 Dec; 36(12):1958-1971. PubMed ID: 25315404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
